Drug stocks retrench with broad market;
Drug stocks retrenched in early action Tuesday as the broader market slumped on disappointing US retail-sales figures for March.
Drug stocks were a mixed bag early Thursday as the broader market climbed ahead of a highly-anticipated meeting of the G20 member states to discuss how to tackle the on-going global economic crisis.